Aurora Spine, Carlsmed and Shoulder Innovations are innovative companies with exciting growth opportunities as the orthopedic market evolves.

3 Smaller Companies with Compelling Growth Opportunities

Aurora Spine, Carlsmed and Shoulder Innovations are innovative companies with exciting growth opportunities as the orthopedic market evolves.

ATEC Launches PTP Corpectomy, The Next Evolution of Lateral Approach Surgery

Spine M&A Ticks Up As Market Evolves

Our chart of the month tracks spine M&A activity over the last decade, including the seven deals done so far in 2025.

A look at the current state of the foot and ankle market, the growth of core trauma and ways that smaller players are leveraging niche subsegments.

State of the Trauma Market 2025

A look at the current state of the foot and ankle market, the growth of core trauma and ways that smaller players are leveraging niche subsegments.

Orthoflash®
Amber Implants VCFix
Amber Implants Secures FDA 510(k) Clearance for VCFix

The VCFix Spinal System is a vertebral augmentation system designed to treat a broad spectrum of vertebral compression fractures.

,
Keri Medical TOUCH CMC 1 Implant
First TOUCH CMC 1 Prosthesis Implanted in the US

Medartis’ TOUCH implant addresses a clinical need in hand surgery, as the CMC 1 joint is among the most commonly affected by osteoarthritis.

,
HyperFlex Medical Bunion Correction
First Case in Clinical Evaluation of HyperFlex Bunion Correction

HyperFlex Bunion Correction is designed for early intervention, aiming to reduce pain, accelerate recovery and lower complication risk.

,
SutureTech Announces FDA 510(k) Clearance for RapidFix
SutureTech Gains FDA 510(k) Clearance for RapidFix

Cleared by FDA as the All-Suture Dual Anchor System, RapidFix is intended for fixation of soft tissue to bone in a variety of orthopedic procedures.

,
BONESUPPORT Cerament G Bone Graft Substitute
BONESUPPORT’s Cerament Demonstrates Strong Results in Trauma Cases

At follow-up after 11 months, treatment success, defined as complete regression of infection without recurrence, was observed in 96.1% of patients.

,
Competitive Landscape
Industry Voices

Contact Us

0